DK2520670T3 - Nye polymorphier i ABCB1 forbundet med en mangel på klinisk respons over for lægemidler - Google Patents
Nye polymorphier i ABCB1 forbundet med en mangel på klinisk respons over for lægemidlerInfo
- Publication number
- DK2520670T3 DK2520670T3 DK12179060T DK12179060T DK2520670T3 DK 2520670 T3 DK2520670 T3 DK 2520670T3 DK 12179060 T DK12179060 T DK 12179060T DK 12179060 T DK12179060 T DK 12179060T DK 2520670 T3 DK2520670 T3 DK 2520670T3
- Authority
- DK
- Denmark
- Prior art keywords
- abcb1
- drugs
- lack
- clinical response
- new polymorphisms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94333507P | 2007-06-12 | 2007-06-12 | |
| EP08759217A EP2158331B1 (en) | 2007-06-12 | 2008-06-12 | New polymorphisms in abcb1 associated with a lack of clinical response to medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2520670T3 true DK2520670T3 (da) | 2014-05-26 |
Family
ID=39735268
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK12179060T DK2520670T3 (da) | 2007-06-12 | 2008-06-12 | Nye polymorphier i ABCB1 forbundet med en mangel på klinisk respons over for lægemidler |
| DK08759217T DK2158331T3 (da) | 2007-06-12 | 2008-06-12 | Nye polymorfier i ABCB1 i sammenhæng med mangel på klinisk respons over for lægemidler |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK08759217T DK2158331T3 (da) | 2007-06-12 | 2008-06-12 | Nye polymorfier i ABCB1 i sammenhæng med mangel på klinisk respons over for lægemidler |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9115398B2 (da) |
| EP (2) | EP2520670B1 (da) |
| DK (2) | DK2520670T3 (da) |
| ES (2) | ES2394529T3 (da) |
| PL (2) | PL2520670T3 (da) |
| WO (1) | WO2008151803A2 (da) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110023146A1 (en) * | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Genomic editing of genes involved in secretase-associated disorders |
| US20110023140A1 (en) * | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Rabbit genome editing with zinc finger nucleases |
| US20110016540A1 (en) * | 2008-12-04 | 2011-01-20 | Sigma-Aldrich Co. | Genome editing of genes associated with trinucleotide repeat expansion disorders in animals |
| US20110030072A1 (en) * | 2008-12-04 | 2011-02-03 | Sigma-Aldrich Co. | Genome editing of immunodeficiency genes in animals |
| US20110023151A1 (en) * | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Genome editing of abc transporters |
| US20110023139A1 (en) * | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Genomic editing of genes involved in cardiovascular disease |
| US20110016541A1 (en) * | 2008-12-04 | 2011-01-20 | Sigma-Aldrich Co. | Genome editing of sensory-related genes in animals |
| US20110023145A1 (en) * | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Genomic editing of genes involved in autism spectrum disorders |
| US20110023143A1 (en) * | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Genomic editing of neurodevelopmental genes in animals |
| US20110023141A1 (en) * | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Genomic editing of genes involved with parkinson's disease |
| US20110023156A1 (en) * | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Feline genome editing with zinc finger nucleases |
| US20110016539A1 (en) * | 2008-12-04 | 2011-01-20 | Sigma-Aldrich Co. | Genome editing of neurotransmission-related genes in animals |
| US20110016546A1 (en) * | 2008-12-04 | 2011-01-20 | Sigma-Aldrich Co. | Porcine genome editing with zinc finger nucleases |
| US20110023153A1 (en) * | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Genomic editing of genes involved in alzheimer's disease |
| US20110023148A1 (en) * | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Genome editing of addiction-related genes in animals |
| US20110023154A1 (en) * | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Silkworm genome editing with zinc finger nucleases |
| US20110023149A1 (en) * | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Genomic editing of genes involved in tumor suppression in animals |
| US20110023144A1 (en) * | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Genomic editing of genes involved in amyotrophyic lateral sclerosis disease |
| US20110016543A1 (en) * | 2008-12-04 | 2011-01-20 | Sigma-Aldrich Co. | Genomic editing of genes involved in inflammation |
| US20110023158A1 (en) * | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Bovine genome editing with zinc finger nucleases |
| US20110023150A1 (en) * | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Genome editing of genes associated with schizophrenia in animals |
| US20110023147A1 (en) * | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Genomic editing of prion disorder-related genes in animals |
| US20110023152A1 (en) * | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Genome editing of cognition related genes in animals |
| CA2821547A1 (en) | 2010-12-29 | 2012-07-05 | Sigma-Aldrich Co. Llc | Cells having disrupted expression of proteins involved in adme and toxicology processes |
| WO2012103060A1 (en) * | 2011-01-27 | 2012-08-02 | Glaxo Wellcome Manufacturing Pte Ltd | Method of administration and treatment |
| CN102912003A (zh) * | 2011-08-02 | 2013-02-06 | 广州益善生物技术有限公司 | 一种abcb1基因多态性检测特异性引物和液相芯片 |
| GB201210686D0 (en) * | 2012-06-15 | 2012-08-01 | Holsboermaschmeyer Neurochemie Gmbh | V1B receptor antagonist for use in the treatment of patients having an elevated AVP level and/or an elevated copeptin level |
| US11694539B2 (en) * | 2020-06-16 | 2023-07-04 | Heartware, Inc. | Notification system for low-level preventative LVAD alerts |
| CN113584160A (zh) * | 2021-06-15 | 2021-11-02 | 湖南菲思特精准医疗科技有限公司 | 一种昂司丹琼代谢标志物检测试剂盒及其检测方法和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001009183A2 (en) | 1999-07-30 | 2001-02-08 | Epidauros | Polymorphisms in the human mdr-1 gene and applications thereof |
| US7034036B2 (en) | 2000-10-30 | 2006-04-25 | Pain Therapeutics, Inc. | Inhibitors of ABC drug transporters at the blood-brain barrier |
| ES2397345T3 (es) | 2004-05-12 | 2013-03-06 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Método para detectar polimorfismos en el gen de la ABCB1 asociados con una falta de respuesta a un medicamento activo en el SNC y medicamento que comprende un agente inhibidor de la ABCB1 para su uso en el tratamiento de enfermedades relacionadas con el SNC |
-
2008
- 2008-06-12 PL PL12179060T patent/PL2520670T3/pl unknown
- 2008-06-12 WO PCT/EP2008/004737 patent/WO2008151803A2/en active Application Filing
- 2008-06-12 DK DK12179060T patent/DK2520670T3/da active
- 2008-06-12 ES ES08759217T patent/ES2394529T3/es active Active
- 2008-06-12 EP EP20120179060 patent/EP2520670B1/en active Active
- 2008-06-12 PL PL08759217T patent/PL2158331T3/pl unknown
- 2008-06-12 DK DK08759217T patent/DK2158331T3/da active
- 2008-06-12 ES ES12179060T patent/ES2456919T3/es active Active
- 2008-06-12 US US12/663,997 patent/US9115398B2/en active Active
- 2008-06-12 EP EP08759217A patent/EP2158331B1/en active Active
-
2015
- 2015-07-16 US US14/800,848 patent/US9901582B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20160067262A1 (en) | 2016-03-10 |
| WO2008151803A2 (en) | 2008-12-18 |
| WO2008151803A3 (en) | 2009-02-26 |
| PL2520670T3 (pl) | 2014-07-31 |
| PL2158331T3 (pl) | 2013-01-31 |
| ES2456919T3 (es) | 2014-04-24 |
| EP2520670B1 (en) | 2014-02-26 |
| DK2158331T3 (da) | 2012-12-17 |
| EP2158331B1 (en) | 2012-08-29 |
| US9115398B2 (en) | 2015-08-25 |
| US20100184742A1 (en) | 2010-07-22 |
| EP2158331A2 (en) | 2010-03-03 |
| US9901582B2 (en) | 2018-02-27 |
| ES2394529T3 (es) | 2013-02-01 |
| EP2520670A1 (en) | 2012-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2520670T3 (da) | Nye polymorphier i ABCB1 forbundet med en mangel på klinisk respons over for lægemidler | |
| CY2020008I2 (el) | Φαρμακοτεχνικες μορφες διστρωματικου δισκιου | |
| EP2561352A4 (en) | GENETIC POLYMORPHISMS ASSOCIATED WITH STATIN RESPONSE AND CARDIOVASCULAR DISEASES, DETECTION METHODS AND USES THEREOF | |
| SMT201700095B (is) | Composizioni farmaceutiche per inalazione | |
| DK2046941T4 (da) | Forbedret tilslutning til engangsbioreaktorbeholder | |
| EP2310525A4 (en) | ASSOCIATED GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISEASES, DETECTION METHODS AND THEIR USE | |
| DK3097925T3 (da) | Farmaceutisk sammensætning | |
| DK2236598T3 (da) | Mikroorganismer til forbedring af helbredet hos individer med lidelser i forbindelse med fordøjelse af gluten | |
| DK2307381T3 (da) | Nye lægemidler til inhibering af aggregering af proteiner involveret i sygdomme forbundet med proteinaggregering og/eller neurodegenerative sygdomme | |
| BRPI1004940A2 (pt) | composição farmacêutica | |
| DK2403510T3 (da) | Bakteriestammer med en høj antiinflammatorisk aktivitet | |
| ATE557381T1 (de) | Präsentationssäule | |
| DE06722936T8 (de) | Isomerisation pharmazeutischer zwischenprodukte | |
| DK2442799T3 (da) | Fast farmaceutisk sammensætning omfattende rivaroxaban | |
| DK2482899T3 (da) | Konstruktion til indretning til indgivelse af lægemiddel | |
| BRPI1015939A2 (pt) | composição farmacêutica | |
| DK2164520T3 (da) | Cyclodextriner til indgivelse af fedtsyrer i tabletter | |
| DK2435576T3 (da) | Enzymkombination til at gøre biomasse flydende | |
| IL231723A0 (en) | Single nucleotide polymorphisms (branches) that allow predicting the response to glatiramer acetate | |
| DK2391349T3 (da) | Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater | |
| DK1864716T3 (da) | Lukke til en bioreaktor med milliliter-skala | |
| EE201300004A (et) | Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks | |
| FR2933987B1 (fr) | Procede d'hydrogenation du benzene | |
| EP2622101A4 (en) | GENETIC VARIATIONS OF INTERLEUKIN-6 RECEPTOR GENE FOR PREDICTING PATIENT RESPONSE TO TREATMENT BASED ON INHIBITORS OF INTERLEUKIN-6 RECEPTOR | |
| BR112012003149A2 (pt) | composição farmacêutica |